Literature DB >> 2695876

Sorsby's fundus dystrophy.

W K Hamilton1, C C Ewing, E J Ives, J D Carruthers.   

Abstract

Ever since Sorsby described his pseudoinflammatory dystrophy in five families, its characteristics have been unclear. The findings in ten affected members of a seven-generation pedigree are discussed and the literature is reviewed. Patients with this dominantly inherited fundus dystrophy lose central vision between the second and fourth decade of life. Three variations in the fundus appearances were distinguished: in the first and most common, white to yellow fundus spots (which are not drusen) accompany a disciform macular degeneration; in the second, the fundus spots are absent; in the third, the yellow deposits are associated with atrophic macular degeneration. Atrophy of the retina, pigment epithelium, and choroid then slowly progresses toward the periphery. Treatment does not halt the progress of the disease. Although variations in this dystrophy may be examples of genetic heterogeneity, Sorbsy's fundus dystrophy is a distinct clinical disorder.

Entities:  

Mesh:

Year:  1989        PMID: 2695876     DOI: 10.1016/s0161-6420(89)32647-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

2.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

Authors:  M A Majid; V A Smith; F J Matthews; A C Newby; A D Dick
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

Review 3.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

4.  Sorsby fundus dystrophy without a mutation in the TIMP-3 gene.

Authors:  J J Assink; E de Backer; J B ten Brink; T Kohno; P T de Jong; A A Bergen; F Meire
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

Review 5.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

6.  A twin study on age-related macular degeneration.

Authors:  S M Meyers
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 7.  Sorsby fundus dystrophy: Insights from the past and looking to the future.

Authors:  Bela Anand-Apte; Jennifer R Chao; Ruchira Singh; Heidi Stöhr
Journal:  J Neurosci Res       Date:  2018-08-21       Impact factor: 4.164

8.  Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.

Authors:  P A Sieving; S Boskovich; E Bingham; H Pawar
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 9.  Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby's Fundus Dystrophy: A Systematic Review.

Authors:  Arthur Baston; Christin Gerhardt; Souska Zandi; Justus G Garweg
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 10.  Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Authors:  Carla B Mellough; David H W Steel; Majlinda Lako
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.